Case report links imported pediatric medications contaminated with diethylene glycol to acute kidney injury in Gambian children

A case report from The Gambia describes acute kidney injury in children linked to imported pediatric medications found to be contaminated with diethylene glycol. The report does not specify the number of children affected, the exact medications involved, or provide a comparator group. The primary outcome of acute kidney injury was reported as linked to the exposure, but no specific effect size, absolute numbers, or statistical measures were provided.

Safety and tolerability data, including adverse events and discontinuations, were not reported in this case description. The authors note the association as likely, but the evidence is limited to this single, descriptive report.

Key limitations include the inherent nature of a case report, which cannot establish causality or quantify risk. The lack of reported sample size, comparator data, and specific clinical details significantly restricts interpretation. Funding sources and potential conflicts of interest were not disclosed.

For clinical practice, this report serves as a cautionary signal regarding the potential dangers of medication contamination, particularly in specific import contexts. It underscores the importance of pharmacovigilance and supply chain security but does not provide evidence to guide specific diagnostic or treatment changes.